Publications:

Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms.

Hemasphere

Luque Paz, Damien D; Bader, Michael S MS; Nienhold, Ronny R; Rai, Shivam S; Almeida Fonseca, Tiago T; Stetka, Jan J; Hao-Shen, Hui H; Mild-Schneider, Gabriele G; Passweg, Jakob R JR; Skoda, Radek C RC

Publication Date: 2023-05

Variant appearance in text: TET2: S585X

PubMed Link: 37153874

Variant Present in the following documents:

• hs9-7-e885-s003.pdf
• hs9-7-e885-s001.xlsx, sheet 2

View BVdb publication page

Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm.

Nature Communications

Rai, Shivam S; Grockowiak, Elodie E; Hansen, Nils N; Luque Paz, Damien D; Stoll, Cedric B CB; Hao-Shen, Hui H; Mild-Schneider, Gabriele G; Dirnhofer, Stefan S; Farady, Christopher J CJ; Méndez-Ferrer, Simón S; Skoda, Radek C RC

Publication Date: 2022-09-13

Variant appearance in text: TET2: Ser585X

PubMed Link: 36100613

Variant Present in the following documents:

• 41467_2022_32927_MOESM4_ESM.xlsx, sheet 1

View BVdb publication page

Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.

Nature Genetics

Kar, Siddhartha P SP; Quiros, Pedro M PM; Gu, Muxin M; Jiang, Tao T; Mitchell, Jonathan J; Langdon, Ryan R; Iyer, Vivek V; Barcena, Clea C; Vijayabaskar, M S MS; Fabre, Margarete A MA; Carter, Paul P; Petrovski, Slavé S; Burgess, Stephen S; Vassiliou, George S GS

Publication Date: 2022-08

Variant appearance in text: TET2: S585*

PubMed Link: 35835912

Variant Present in the following documents:

• 41588_2022_1121_MOESM3_ESM.xlsx, sheet 4

View BVdb publication page

Gastrointestinal Myeloid Sarcoma a Case Presentation and Review of the Literature.

Mediterranean Journal Of Hematology And Infectious Diseases

Kheirkhah, Pouyan P; Avila-Rodriguez, Ana M AM; Radzik, Bartlomiej B; Murga-Zamalloa, Carlos C

Publication Date: 2021

Variant appearance in text: TET2: S585*

PubMed Link: 34804441

Variant Present in the following documents:

• Main text
• mjhid-13-1-e2021067.pdf

View BVdb publication page

Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease.

Leukemia

Dawoud, Ahmed A Z AAZ; Gilbert, Rodney D RD; Tapper, William J WJ; Cross, Nicholas C P NCP

Publication Date: 2022-02

Variant appearance in text: TET2: S585X

PubMed Link: 34413458

Variant Present in the following documents:

• 41375_2021_1382_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page